Related Experiment Video
Updated: Aug 15, 2026
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Published on: September 16, 2019
[Inhibitory effect of potential metastasis in SGC-7901 cells induced by beta-ionone]
Jia-Ren Lin1, Bing-Qing Chen, Yan-Mei Yang
1School of Public Health, Harbin Medical University, Harbin 150086, China.
Objective:
To determine the effect of beta-ionone on the potential metastasis of human gastric adenocarcinoma cell line SGC-7901 and the underlying mechanism.
Methods:
Using curve of cellular growth, Zymograms, and RT-PCR assays, we analyzed the growth rate, the activities of two types IV collagenase of Matrix met alloproteinase 9 (MMP-9) and MMP-2 and the expression of nm23-H1 gene, tissue inhibitor of met alloproteinase 1 (TIMP-1) and TIMP-2 in SGC-7901 cells which were treated with progressively increasing concentrations (25, 50, 100 and 200 micromol/L) of beta-ionone for 24 h and 48 h.
Results:
The growth of SGC-7901 cells was inhibited by beta-ionone. Eight days after treatment with different concentrations of beta-ionone, as mentioned above, the inhibition rates were 25.93%, 28.21%, 74.36% and 90.11%, respectively compared to the negative control. The estimated IC50 value of beta-ionone for SGC-7901 cells was estimated to be 89 micromol/L; beta-ionone did not show any effect on the activities of MMP-9 and MMP-2 in SGC-7901 cells. However, the expression of nm23-H1, TIMP-1 and TIMP-2 mRNA transcripts gradually increased in response to beta-ionone in a dose-dependent manner.
Conclusion:
beta-ionone can inhibit the growth and proliferation of SGC-7901 cells. It may show some effects on the potential metastasis of SGC-7901 cells indicates by its upregulation of nm23-H1, TIMP-1 and TIMP-2 expression. However, beta-ionone may have no effect on the activities of type IV collagenase in SGC-7901 cells. The mechanism by which beta-ionone inhibits the potential metastasis of SGC-7901 cells needs to be studied further.
Insights
Beta-ionone effectively inhibits gastric adenocarcinoma cell growth. While not impacting collagenase activity, it upregulates metastasis-inhibiting genes, suggesting potential anti-metastatic effects requiring further investigation.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Context:
- Gastric adenocarcinoma (SGC-7901 cell line) is a significant global health concern.
- Understanding the molecular mechanisms of metastasis is crucial for developing effective cancer therapies.
- Beta-ionone, a naturally occurring compound, has shown potential in preliminary cancer research.
Purpose:
- To investigate the anti-proliferative and anti-metastatic effects of beta-ionone on human gastric adenocarcinoma cells (SGC-7901).
- To elucidate the underlying molecular mechanisms, focusing on gene and protein expression related to metastasis.
Summary:
- Beta-ionone demonstrated dose-dependent inhibition of SGC-7901 cell growth, with an IC50 of 89 micromol/L.
- While beta-ionone did not affect Matrix metalloproteinase 9 (MMP-9) or MMP-2 activity, it significantly upregulated the expression of nm23-H1, Tissue inhibitor of metalloproteinase 1 (TIMP-1), and TIMP-2 mRNA.
- These findings suggest that beta-ionone may inhibit metastasis through mechanisms involving the upregulation of specific metastasis-suppressing genes.
Impact:
- Provides evidence for beta-ionone's potential as a therapeutic agent against gastric cancer.
- Identifies specific molecular targets (nm23-H1, TIMP-1, TIMP-2) for future drug development.
- Highlights the need for further research into the precise anti-metastatic pathways influenced by beta-ionone.
